Results

Total Results: 2,231 records

Showing results for "medication".
Users also searched for: medication reconciliation

61. Archived: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication-december-2017
    December 12, 2017 - Preventive Medication Hormone therapy refers to the use of combined estrogen and progestin in women … at increased risk of breast cancer who do not have contraindications and are at low risk of adverse medication … Harms of Preventive Medication Combined Estrogen and Progestin The USPSTF found convincing evidence … Benefits and Harms of Preventive Medication The USPSTF found 18 fair- or good-quality trials comparing … Timing of Preventive Medication It has been proposed that hormone therapy initiated closer to the time

62. Evidence Summary: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication
    December 12, 2017 - Evidence Summary Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions December 12, 2017 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Depart…

63. Evidence Summary: Statins for Prevention of Cardiovascular Disease in Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication
    November 13, 2016 - Disease in Adults Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication … recommendation statement: statin use for the primary prevention of cardiovascular disease in adults: preventive medication … HbA1c <12% SBP <200 mm Hg DBP <110 mm Hg Not receiving any other lipid-lowering medication … and 15 to 300 mg/24 h in two 24-h samples) Blood pressure <160/100 mm Hg and no antihypertensive medication … TC <309 mg/dL or <193 mg/dL if previous MI No lipid lowering medication 4 y Moderate

64. Archived: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication-2009
    March 15, 2009 - Final Recommendation Statement Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication … Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication … Benefits of Preventive Medication The USPSTF found good evidence that aspirin decreases the incidence … Harms of Preventive Medication The USPSTF found good evidence that aspirin increases the incidence … Potential Harms of Risk Assessment and Preventive Medication Using aspirin for the primary prevention

65. Archived: Falls Prevention in Older Adults: Counseling and Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/falls-prevention-in-older-adults-counseling-and-preventive-medication-2012
    May 15, 2012 - Final Recommendation Statement Falls Prevention in Older Adults: Counseling and Preventive Medication … More efficacy trials are needed of the following interventions: vision correction, medication withdrawal … for falling; other clinical management interventions, including vision correction, hip protectors, medication … The design of trials that included medication discontinuation interventions varied, thus preventing the … The USPSTF found no evidence of serious harms from hip protectors, medication, protein supplementation

66. Archived: Folic Acid to Prevent Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-to-prevent-neural-tube-defects-preventive-medication-2009
    May 15, 2009 - Final Recommendation Statement Folic Acid to Prevent Neural Tube Defects: Preventive Medication … Timing of Medication Start supplementation at least 1 month before conception. … Benefits of Preventive Medication The USPSTF found convincing evidence that supplements containing … Harms of Preventive Medication Adequate evidence suggests that folic acid from supplementation at usual … Effectiveness of Preventive Medication In addition to the RCT that was available in 1996, the USPSTF

67. Archived: Vitamin D and Calcium to Prevent Fractures: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-d-and-calcium-to-prevent-fractures-preventive-medication-2013
    February 15, 2013 - Final Recommendation Statement Vitamin D and Calcium to Prevent Fractures: Preventive Medication … Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication … Supplementation for the Primary Prevention of Falls and Fractures in Community-Dwelling Adults: Preventive Medication … Benefits of Preventive Medication In premenopausal women and in men, there is inadequate evidence to … Harms of Preventive Medication Adequate evidence indicates that supplementation with 400 IU or less

68. Archived: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
    March 15, 2007 - Final Recommendation Statement Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication … Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication

69. Draft Recommendation: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-preeclampsia-and-related-morbidity-and-mortality-preventive-medication1
    February 23, 2021 - Recommendation Statement Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication … in Progress for Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication … risk for preeclampsia The USPSTF recommends the use of low-dose aspirin (81 mg/day) as preventive medication … Benefits of Risk Assessment and Preventive Medication The USPSTF considered 18 randomized, controlled … Summary of USPSTF Rationale Rationale Assessment Benefits of preventive medication There is

70. Final Research Plan: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
    May 14, 2020 - in progress Final Research Plan Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication

71. Draft Research Plan: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
    January 30, 2020 - in progress Draft Research Plan Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication

72. Final Evidence Review: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/menopausal-hormone-therapy-preventive-medication
    November 01, 2022 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Evidence Review Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions November 01, 2022 Recommendations made by the USPSTF are independent of…

73. Evidence Summary: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary28/menopausal-hormone-therapy-preventive-medication
    November 01, 2022 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions November 01, 2022 Recommendations made by the USPSTF are independent of the …

74. Final Research Plan: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/menopausal-hormone-therapy-preventive-medication
    May 27, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Research Plan Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions May 27, 2021 Recommendations made by the USPSTF are independent of t…

75. Archived: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 2002 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-use-prevent-cardiovascular-disease-colorectal-cancer-preventive-medication-2002
    January 01, 2002 - Recommendations and Rationale Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication … Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication

76. U.S. Preventive Services Task Force Issues Final Recommendation Statement for Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/announcements/us-preventive-services-task-force-issues-final-recommendation-statement-ocular-prophylaxis-gonococcal-ophthalmia-neonatorum
    July 28, 2011 - Force (USPSTF) has reaffirmed its 2005 recommendation that all newborns should receive topical eye medication … available at /uspstf/recommendation/ocular-prophylaxis-for-gonococcal-ophthalmia-neonatorum-preventive-medication

77. Draft Evidence Review: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication
    May 04, 2021 - Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication

78. Archived: Vitamin Supplementation to Prevent Cancer and CVD: Counseling and Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling-and-preventive-medication
    June 15, 2003 - Recommendation Statement Vitamin Supplementation to Prevent Cancer and CVD: Counseling and Preventive Medication … Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication … ) Recommendation Summary Population Recommendation Grade Preventive Medication … D Preventive Medication -- Vitamins A, C, E, Multivitamin with Folic Acid The USPSTF concludes … final-evidence-summary53/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling-and-preventive-medication

79. Final Research Plan: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/ocular-prophylaxis-for-gonococcal-ophthalmia-neonatorum-preventive-medication
    February 08, 2018 - Final Research Plan Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication

80. Public Comment on Draft Recommendation: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-recommendation-ocular-prophylaxis-gonococcal-ophthalmia-neonatorum
    September 13, 2010 - USPSTF) is inviting public comment on its draft recommendation statement on prophylactic ocular topical medication … recommendation is a reaffirmation of the USPSTF's 2005 recommendation in support of prophylactic ocular topical medication